title: The use of phosphate binders: data from contributors to the European Practice Database.
abstract: Data of the European Practice Database (EPD) were used to investigate the use of phosphate binders in the European HD population. A cross-sectional observation among five participating countries of the cycle 2 study revealed that most patients used phosphate binders and many of them used more than one agent. Calcium-based products were most frequently used (55% of HD patients) followed by sevelamer (37%). There was a wide variation between different countries in the kind of phosphates that were used. Renal dietitians advised regularly on therapy adjustment for calcium/phosphorus metabolism in one third of European centres and their involvement is increasing.
authors.affiliation: Department of Nursing Sciences, University of Antwerp, Antwerpen, Belgium. monique.elseviers@ua.ac.be
authors.forename: Monique
authors.initials: M
authors.lastname: Elseviers
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: De Vos
mesh_terms: D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use; D017607:Aluminum Compounds / Q000627:therapeutic use; D000704:Analysis of Variance; D002119:Calcium Carbonate / Q000009:adverse effects / Q000627:therapeutic use; D017610:Calcium Compounds / Q000009:adverse effects / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use*; D003430:Cross-Sectional Studies; D016208:Databases, Factual; D004046:Dietetics / Q000706:statistics & numerical data; D004363:Drug Utilization / Q000706:statistics & numerical data*; D005060:Europe; D019538:Health Care Surveys; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D007811:Lanthanum / Q000627:therapeutic use; D009398:Nephrology / Q000706:statistics & numerical data*; D011073:Polyamines / Q000627:therapeutic use; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D006435:Renal Dialysis; D000069603:Sevelamer; D011795:Surveys and Questionnaires; D014807:Vitamin D / Q000031:analogs & derivatives
chemical_list: D000085:Acetates; D017607:Aluminum Compounds; D017610:Calcium Compounds; D002614:Chelating Agents; D011073:Polyamines; D014807:Vitamin D; C119467:lanthanum carbonate; D007811:Lanthanum; D000069603:Sevelamer; D002119:Calcium Carbonate; C120662:calcium acetate